TransMedics CFO awarded 17,246 RSUs, 26,153 options

Hernandez Gerardo reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hernandez Gerardo reported acquisition or exercise transactions in this Form 4 filing.

TransMedics Group, Inc. Chief Financial Officer Gerardo Hernandez received equity awards on 2026-07-10 consisting of 17,246 RSUs, each representing one share of common stock, and stock options for 26,153 shares at $71.23 per share, vesting monthly from April 10, 2026 through April 10, 2030. Following these grants, he holds 31,935 common shares directly and 26,153 options expiring July 10, 2036.

Insider Trade Summary

Grant/Award: 43,399 shares

Grant/Award 2 txns

Insider Hernandez Gerardo

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F2	26,153	$0.00	$0.00
Grant/Award	Common Stock F1	17,246	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 26,153 contracts (Direct); Common Stock — 31,935 shares (Direct)

Footnotes (2)

1. F1. Consists of 17,246 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2. F2. The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.

Key Figures

RSUs granted: 17,246 shares Options granted: 26,153 shares Option exercise price: $71.23 per share +4 more

7 metrics

RSUs granted 17,246 shares Restricted stock units granted to CFO on 2026-07-10

Options granted 26,153 shares Stock options (right to buy) granted on 2026-07-10

Option exercise price $71.23 per share Conversion or exercise price of stock option grant

Option expiration 2036-07-10 Expiration date of the stock option grant

Vesting rate 2.0833% per month Monthly vesting rate from April 10, 2026 until April 10, 2030

Common shares after grant 31,935 shares Total common stock directly held by CFO after RSU grant

Options held after grant 26,153 options Total stock options directly held by CFO after grant

Key Terms

restricted stock units ("RSUs"), RSUs, Stock Option (Right to Buy), vests, +1 more

5 terms

restricted stock units ("RSUs") financial

"Consists of 17,246 restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

RSUs financial

"Each RSU represents a contingent right to receive one share"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) with an exercise price of $71.23"

vests financial

"The option vests at a rate of 2.0833% of the total number"

contingent right financial

"Each RSU represents a contingent right to receive one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did TransMedics (TMDX) CFO Gerardo Hernandez report?

CFO Gerardo Hernandez reported receiving 17,246 restricted stock units and stock options for 26,153 shares at $71.23 on 2026-07-10. These are equity compensation awards rather than open-market purchases or sales of TransMedics common stock.

How many RSUs did the TMDX CFO receive and what do they represent?

Gerardo Hernandez received 17,246 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of TransMedics common stock, meaning the shares are delivered only if the vesting and service conditions are satisfied.

What are the terms of the new stock options granted to the TMDX CFO?

He was granted stock options covering 26,153 shares of TransMedics common stock with an exercise price of $71.23 per share. The options expire on July 10, 2036, providing a long-dated right to buy shares at that fixed price once vested.

When do TransMedics (TMDX) CFO Gerardo Hernandez’s new options vest?

The option vests at 2.0833% of the total shares each month starting after April 10, 2026, until fully vested on April 10, 2030, subject to his continued service with TransMedics over that period.

How many TransMedics (TMDX) shares does the CFO hold after these grants?

After the reported grants, Gerardo Hernandez holds 31,935 shares of common stock directly and 26,153 stock options. The options give him the right to purchase additional shares at $71.23 per share if he exercises them in the future.

Are the reported TMDX CFO transactions open-market buys or compensation awards?

The transactions are compensation-related awards, coded as "A" grants. They include RSUs and stock options granted at no cash cost per share, rather than open-market purchases or sales of TransMedics stock by the CFO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/14/2026 - 09:33 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hernandez Gerardo

(Last) (First) (Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER MASSACHUSETTS 01810

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/10/2026		A(1)		17,246	A	$0	31,935	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$71.23	07/10/2026		A		26,153		(2)	07/10/2036	Common Stock	26,153	$0	26,153	D

Explanation of Responses:

1. Consists of 17,246 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

2. The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.

	By: /s/ Gerardo Hernandez	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)